ArticleScientific reports2025
Comparison of viscoelastic properties of breast cancer and normal cells using AFM, FLIM and ToF-SIMS techniques.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The modifications in biomechanical properties of cells and tissue are important in cancer progression, including its different aspects, e.g. invasion, migration, adhesion, signaling, interactions with microenvironment, and immune response. However, our understanding of the changes in physical characteristics of cells, and especially the molecular basis for these changes, caused by malignant transformation remains rather limited. While the differences in stiffness and viscoelasticity of tumor and normal cells have been well documented at the cellular scale, subcellular and molecular alterations have been poorly characterised. In our work, we investigated the stiffness and viscoelastic parameters, mainly determined by the actin cortex, and the microviscosity of the plasma membrane, mainly determined by its lipid profile, in normal and cancer cells. The mechanical properties of the cells were assessed using atomic force microscopy (AFM). The microviscosity of the membrane was visualized by fluorescence lifetime imaging microscopy (FLIM) with the viscosity-sensitive probe BODIPY2. Chemical analysis of cell membranes was performed by secondary ion time-of-flight mass spectrometry (ToF-SIMS). The MCF-10 A (normal epithelial cells) and MCF-7 (human breast cancer) cell lines were used in the study. It was shown that cancer cells were more deformable due to a less organized and more isotropic filamentous structure of the actin cytoskeleton. At the same time they had more viscous plasma membranes, compared to normal cells, in both in vitro and tissue conditions. In the membrane lipid profile, increased signals of sphingomyelin and saturated fatty acids and decreased signals of polyunsaturated fatty acids were detected in cancer cells, which explain the higher microviscosity of their membranes. The obtained data indicate a complex reorganization of cell biomechanics at the cellular, subcellular and molecular levels during malignant transformation, which is important for better understanding of fundamental mechanisms of tumor development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.